19-13207858-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001127222.2(CACNA1A):c.6973_6975dupCAG(p.Gln2325dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 152 hom., cov: 0)
Exomes 𝑓: 0.039 ( 283 hom. )
Consequence
CACNA1A
NM_001127222.2 conservative_inframe_insertion
NM_001127222.2 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 19-13207858-C-CCTG is Benign according to our data. Variant chr19-13207858-C-CCTG is described in ClinVar as [Likely_benign]. Clinvar id is 235603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.6973_6975dupCAG | p.Gln2325dup | conservative_inframe_insertion | 47/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6991_6993dupCAG | p.Gln2331dup | conservative_inframe_insertion | 48/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.6979_6981dupCAG | p.Gln2327dup | conservative_inframe_insertion | 47/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.6976_6978dupCAG | p.Gln2326dup | conservative_inframe_insertion | 47/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.6976_6978dupCAG | p.Gln2326dup | conservative_inframe_insertion | 47/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.6940_6942dupCAG | p.Gln2314dup | conservative_inframe_insertion | 46/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.6835_6837dupCAG | p.Gln2279dup | conservative_inframe_insertion | 46/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389 | c.*59_*61dupCAG | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000489992.1 | ||||
CACNA1A | ENST00000637432 | c.*185_*187dupCAG | 3_prime_UTR_variant | 48/48 | 5 | ENSP00000490617.1 | ||||
CACNA1A | ENST00000635895 | c.*185_*187dupCAG | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000490323.1 | ||||
CACNA1A | ENST00000638009 | c.*185_*187dupCAG | 3_prime_UTR_variant | 47/47 | 1 | ENSP00000489913.1 | ||||
CACNA1A | ENST00000637276 | c.*185_*187dupCAG | 3_prime_UTR_variant | 46/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes AF: 0.0341 AC: 5032AN: 147772Hom.: 153 Cov.: 0
GnomAD3 genomes
AF:
AC:
5032
AN:
147772
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0572 AC: 2976AN: 52038Hom.: 83 AF XY: 0.0538 AC XY: 1609AN XY: 29882
GnomAD3 exomes
AF:
AC:
2976
AN:
52038
Hom.:
AF XY:
AC XY:
1609
AN XY:
29882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0393 AC: 50492AN: 1283302Hom.: 283 Cov.: 0 AF XY: 0.0390 AC XY: 24609AN XY: 631626
GnomAD4 exome
AF:
AC:
50492
AN:
1283302
Hom.:
Cov.:
0
AF XY:
AC XY:
24609
AN XY:
631626
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0340 AC: 5023AN: 147874Hom.: 152 Cov.: 0 AF XY: 0.0350 AC XY: 2519AN XY: 71986
GnomAD4 genome
AF:
AC:
5023
AN:
147874
Hom.:
Cov.:
0
AF XY:
AC XY:
2519
AN XY:
71986
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Oct 09, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 21, 2019 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Spinocerebellar ataxia type 6;C1720416:Episodic ataxia type 2;C1832884:Migraine, familial hemiplegic, 1;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 07, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at